James Mulshine to Leukemia, Lymphocytic, Chronic, B-Cell
This is a "connection" page, showing publications James Mulshine has written about Leukemia, Lymphocytic, Chronic, B-Cell.
Connection Strength
0.039
-
Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma. Clin Cancer Res. 1998 Nov; 4(11):2691-700.
Score: 0.039